Amneal Pharmaceuticals, Inc. (AMRX)

19.25 +0.35 (+1.85%) USD  |  NASDAQ  |  Oct 15, 16:00
19.50 +0.25 (+1.30%) Pre-Market: 09:02
More

Amneal Pharmaceuticals SG&A Expense (TTM) : 571.86M for June 30, 2026

SG&A Expense (TTM) Chart

Historical SG&A Expense (TTM) Data

View and export this data back to 1998. Start Trial.
Date Value
June 30, 2026 571.86M
March 31, 2026 547.40M
December 31, 2025 526.83M
September 30, 2025 509.06M
June 30, 2025 489.93M
March 31, 2025 482.13M
December 31, 2024 476.44M
September 30, 2024 456.75M
June 30, 2024 451.07M
March 31, 2024 440.17M
December 31, 2023 429.68M
September 30, 2023 422.83M
June 30, 2023 409.90M
March 31, 2023 403.13M
December 31, 2022 399.70M
September 30, 2022 394.77M
June 30, 2022 386.09M
March 31, 2022 373.44M
December 31, 2021 365.50M
September 30, 2021 352.97M
June 30, 2021 344.69M
March 31, 2021 339.48M
December 31, 2020 326.73M
September 30, 2020 316.12M
June 30, 2020 296.80M
Date Value
March 31, 2020 283.14M
December 31, 2019 289.60M
September 30, 2019 289.75M
June 30, 2019 304.03M
March 31, 2019 289.75M
December 31, 2018 230.44M
September 30, 2018 183.16M
June 30, 2018 132.53M
March 31, 2018 106.46M
December 31, 2017 81.34M
September 30, 2017 111.96M
June 30, 2017 139.56M
March 31, 2017 157.53M
December 31, 2016 201.83M
September 30, 2016 200.76M
June 30, 2016 192.02M
March 31, 2016 195.42M
December 31, 2015 201.29M
September 30, 2015 186.98M
June 30, 2015 179.56M
March 31, 2015 164.07M
December 31, 2014 139.39M
September 30, 2014 126.51M
June 30, 2014 115.59M
March 31, 2014 116.05M

SG&A Expense (TTM) Range, Past 5 Years

View SG&A Expense (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

SG&A Expense (TTM) Benchmarks

View SG&A Expense (TTM) Benchmarks
Start Trial
Liquidia Corp. 192.66M
Eli Lilly & Co. 12.24B
Johnson & Johnson 19.22B
Merck & Co., Inc. 11.14B
Viatris, Inc. 3.981B